Clinical Trials List
Protocol NumberCMUH101-IRB1-264
Not yet recruiting
2013-01-01 - 2013-12-31
Phase II
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
0 participants
